Former Connecticut Residents Charged with Operating Websites to Illegally Sell Misbranded and Unapproved Drugs
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Former Connecticut Residents Charged with Operating Websites to Illegally Sell Misbranded and Unapproved Drugs

Former Connecticut Residents Charged with Operating Websites to Illegally Sell Misbranded and Unapproved Drugs

August 25, 2023
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kristen Govostes
Phone Number: (617) 557-2100

GLASTONBURY, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, has announced that a federal grand jury in New Haven has returned an indictment charging RYAN FIELDS, 49, and LISA MAHAN, 53, of Port Neches, Texas, formerly of Glastonbury, Connecticut, with federal offenses for illegally selling misbranded and unapproved prescription drugs.

The indictment was returned on August 8, 2023, and unsealed after Fields and Mahan were arrested this morning in Port Neches, Texas. They are scheduled to appear this afternoon in U.S. District Court for the Eastern District of Texas.

As alleged in the indictment, from September 2021 to June 2023, Fields and Mahan operated two websites, pinnedaminos.com and projectaminos.com, as well as a private Facebook group called Pinned Aminos, through which they illegally sold and distributed to customers throughout the U.S. misbranded prescription drugs.  They did not require customers to provide a valid prescription, and some of the drugs they sold and distributed were unapproved by the Food and Drug Administration (FDA) for human consumption. The drugs they sold also included drugs they illegally imported from foreign manufacturers.

The indictment further alleges that, to avoid detection and mislead the FDA, the pinnedaminos.com website had a disclaimer that falsely stated that the products for sale were “intended for laboratory and research use only,” and “not intended for human ingestion.”  In addition, the labeling on the drugs sold and delivered to customers falsely stated that the drugs were “research compounds” and/or “not for human consumption.”  Contrary to these representations, Fields and Mahan knew and intended that the drugs they sold were for human use, and through emails and posts on the Pinned Aminos Facebook group, they provided customers with information on the health benefits of the drugs they sold and directions on dosage.

The indictment alleges that Fields and Mahan unlawfully shipped over 10,000 parcels to customers throughout the country and collected more than $1.4 million from customers.  Fields and Mahan used the proceeds to pay themselves, purchase cars, and purchase a residence in Texas.

The indictment charges Fields and Mahan with one count of conspiracy to introduce misbranded or unapproved drugs into interstate commerce and to smuggle goods into the United States, which carries a maximum term of imprisonment of five years, and one count of conspiracy to commit money laundering, which carries a maximum term of imprisonment of 20 years.

U.S. Attorney Avery stressed that an indictment is not evidence of guilt.  Charges are only allegations, and the defendants are presumed innocent unless and until proven guilty beyond a reasonable doubt.

This matter is being investigated by the Food and Drug Administration, Office of Criminal Investigations; the Drug Enforcement Administration; and Homeland Security Investigations.  The case is being prosecuted by Assistant U.S. Attorney Neeraj N. Patel.

U.S. Attorney Avery thanked the U.S. Attorney’s Office for the Eastern District of Texas for their assistance in this matter.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jarod Forget Special Agent in Charge - New England
@DEANewEngland
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster